TURTLE CAMERON (Chief Executive Officer) sold 2.4% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.07M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 6 sales
Filed: 5/2/2026ACC: 0001758363-26-000009
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$1.07M
Total sold
6
Open market trades
0B · 6S
6
Total transactions
15K disposed
Non-Derivative Transactions6
Common Stock
Direct
Shares
−5.30K
Price / share
$69.54
Trade value
$368.56K
% of position
0.8%
5/1/2026
627.54K→622.24K
Common Stock
Direct
Shares
−3.60K
Price / share
$70.77
Trade value
$254.77K
% of position
0.6%
5/1/2026
622.24K→618.64K
Common Stock
Direct
Shares
−1K
Price / share
$71.76
Trade value
$71.76K
% of position
0.2%
5/1/2026
618.64K→617.64K
Common Stock
Direct
Shares
−3.10K
Price / share
$73.14
Trade value
$226.73K
% of position
0.5%
5/1/2026
617.64K→614.54K
Common Stock
Direct
Shares
−1.70K
Price / share
$74.23
Trade value
$126.19K
% of position
0.3%
5/1/2026
614.54K→612.84K
Common Stock
Direct
Shares
−300.00
Price / share
$74.96
Trade value
$22.49K
% of position
0.0%
5/1/2026
612.84K→612.54K
Total
Net shares
−15K
Net value
-$1.07M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | S · Sale | −5.30K | $69.54 | $368.56K | 0.8% | 627.54K | 622.24K |
| Common Stock Direct | 5/1/2026 | S · Sale | −3.60K | $70.77 | $254.77K | 0.6% | 622.24K | 618.64K |
| Common Stock Direct | 5/1/2026 | S · Sale | −1K | $71.76 | $71.76K | 0.2% | 618.64K | 617.64K |
| Common Stock Direct | 5/1/2026 | S · Sale | −3.10K | $73.14 | $226.73K | 0.5% | 617.64K | 614.54K |
| Common Stock Direct | 5/1/2026 | S · Sale | −1.70K | $74.23 | $126.19K | 0.3% | 614.54K | 612.84K |
| Common Stock Direct | 5/1/2026 | S · Sale | −300.00 | $74.96 | $22.49K | 0.0% | 612.84K | 612.54K |
| Total | −15K | -$1.07M | ||||||
Derivative Transactions0
No derivative transactions reported